Clinical Trials in New Taipei City, Zhonghe District
3 recruiting
Showing 1–3 of 3 trials
Recruiting
Phase 2
To Evaluate OBI-833/OBI-821 in Combination With First-Line Erlotinib in Patients With EGFR-Mutated, Globo H-Positive, Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Non-small Cell Lung Cancer
OBI Pharma, Inc60 enrolled7 locationsNCT05442060
Recruiting
Phase 1
ACE2016 in Adult Subjects With Locally Advanced or Metastatic Solid Tumors Expressing Epidermal Growth Factor Receptor (EGFR)
Metastatic Solid TumorLocally Advanced Solid Tumor
Acepodia Biotech, Inc.30 enrolled9 locationsNCT06415487
Recruiting
Phase 4
Comparison of Rigid and Non-Rigid Interbody Fusion Device for Cervical Degenerative Disc Disease in Adults
Cervical disc degeneration
National Taiwan University Hospital180 enrolled13 locationsNCT04550923